Inscripta has filed a notice of an exempt offering of securities to raise $4,399,977.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Inscripta is raising $4,399,977.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Sri Kosaraju played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Inscripta
Inscripta is a life science technology company enabling scientists to solve some of todays most pressing challenges with the first benchtop system for genome editing. The companys automated Onyx platform, consisting of an instrument, consumables, assays, and software, makes CRISPR-based genome engineering accessible to any research lab. Inscripta supports its customers around the world from facilities in Boulder, Colo.; San Diego and Pleasanton, Calif.; and Copenhagen, Denmark.
To learn more about Inscripta, visit http://www.inscripta.com/
Contact:
Sri Kosaraju, Chief Executive Officer
720-759-4088
https://www.linkedin.com/in/sri-kosaraju-a0a8051aa/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.